Final arguments in Google antitrust trial conclude and establish historic ruling

A landmark antitrust trial against Google concluded Friday after a federal judge heard closing arguments, setting the stage for a ...

Why Google Employees Don't React to the US Antitrust Trial

by Technical Terrence Team

05/03/2024

0

On Tuesday, Google employees gathered for a general meeting called TGIF. These company-wide meetings rarely take place on Fridays these ...

Google antitrust trial concludes with closing arguments

by Technical Terrence Team

05/02/2024

0

America's biggest challenge yet to the vast power of today's tech giants has reached its climax.On Thursday and Friday, lawyers ...

Bristol Myers therapy for schizophrenia safe in late-stage trial

by Technical Terrence Team

04/06/2024

0

hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb (New York Stock Exchange:BMY) announced Saturday that its experimental schizophrenia therapy KarXT, acquired ...

EUL jumps 35% as Euler Finance hack returns another $100 million in Ethereum

Bitfinex Hacker Becomes State Witness in Bitcoin Fog Mixer Trial: Report

by Technical Terrence Team

03/03/2024

0

Ilya Lichtenstein, the man behind the looting of billions of dollars from Bitfinex, is now helping federal prosecutors build a ...

Exterior view of the Sanofi headquarters building

Denali Stock Falls as Sanofi Fails Mid-Stage ALS Trial

by Technical Terrence Team

02/16/2024

0

HJBC/iStock Editorial via Getty Images Denali Therapeutics Stock (NASDAQ:DNLI) opened lower on Friday after the company said its partner Sanofi ...

Puma Biotech starts phase II trial for lung cancer therapy

Puma Biotech Begins Phase II Trial for Lung Cancer Therapy By Investing.com

by Technical Terrence Team

02/13/2024

0

IMF says AI will impact nearly 40% of jobs worldwide (NYSEARCA:CHAT)

Ionis Angioedema Drug Shows Positive Results in Phase 3 Trial (NASDAQ:IONS)

by Technical Terrence Team

01/22/2024

0

Ionis Pharmaceuticals (NASDAQ:IONS) on Monday announced positive results from the Phase 3 trial of its drug candidate donidalorsen for hereditary ...

Handrawn illustration of human Lungs on light grey background.

Theravance shares fall as late-stage trial for Yupelri fails

by Technical Terrence Team

01/05/2024

0

mi-viri/iStock via Getty Images Theravance Biopharmacy (NASDAQ: TBPH) lost ~16% premarket on Friday after announcing that Yupelri, its FDA-approved therapy ...